Marshall S. Stanton insider trades: Artivion (AORT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Marshall reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | AORT | ↓ Sell | 2,149 | $37.78 | $81K | Direct | Mar 4, 2026 (1d) |
| Mar 2, 2026 | AORT | ↓ Sell | 1,513 | $38.02 | $58K | Direct | Mar 3, 2026 (1d) |
| Feb 24, 2026 | AORT | ↓ Sell | 3,682 | $36.94 | $136K | Direct | Feb 25, 2026 (1d) |
| Nov 21, 2025 | AORT | ↓ Sell | 47,376 | $45.04 | $2.1M | Direct | Nov 24, 2025 (3d) |
| Nov 20, 2025 | AORT | ↓ Sell | 15,276 | $44.18 | $675K | Direct | Nov 24, 2025 (4d) |
| Nov 13, 2025 | AORT | ↓ Sell | 4,993 | $45.86 | $229K | Direct | Nov 14, 2025 (1d) |
| Nov 10, 2025 | AORT | ↓ Sell | 2,566 | $44.62 | $114K | Direct | Nov 12, 2025 (2d) |
| Aug 27, 2025 | AORT | ↓ Sell | 18,200 | $44.02 | $801K | Direct | Aug 28, 2025 (1d) |
| Jun 17, 2025 | AORT | ↓ Sell10b5-1 | 15,000 | $29.50 | $443K | Direct | Jun 18, 2025 (1d) |
| Jun 13, 2025 | AORT | ↓ Sell10b5-1 | 26,132 | $28.44 | $743K | Direct | Jun 16, 2025 (3d) |
| May 9, 2025 | AORT | ↓ Sell | 10,548 | $29.13 | $307K | Direct | May 12, 2025 (3d) |
| Mar 6, 2025 | AORT | ↓ Sell | 1,603 | $24.80 | $40K | Direct | Mar 10, 2025 (4d) |
| Feb 24, 2025 | AORT | ↓ Sell | 4,687 | $27.31 | $128K | Direct | Feb 26, 2025 (2d) |
| Mar 20, 2024 | AORT | ↓ Sell | 2,183 | $20.39 | $45K | Direct | Mar 21, 2024 (1d) |
| Mar 5, 2024 | AORT | ↓ Sell | 1,506 | $18.72 | $28K | Direct | Mar 7, 2024 (2d) |
| Feb 27, 2024 | AORT | ↓ Sell | 465 | $19.83 | $9K | Direct | Feb 29, 2024 (2d) |
| Feb 26, 2024 | AORT | ↓ Sell | 3,048 | $20.27 | $62K | Direct | Feb 28, 2024 (2d) |
| Mar 2, 2023 | AORT | ↓ Sell | 907 | $13.41 | $12K | Direct | Mar 3, 2023 (1d) |
| Feb 27, 2023 | AORT | ↓ Sell | 2,337 | $12.94 | $30K | Direct | Mar 1, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AORT insiders
Open-market trades in the last 12 months
About Marshall S. Stanton's insider trades
Marshall S. Stanton is SVP, Clinical & MD Affair at Artivion (AORT). Since Feb 27, 2023, Marshall has reported no open-market purchases and 19 sales worth $6.1M on SEC Form 4. In the last 12 months: 7 sales ($3.4M).
2 sales (20% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (12 filings), option exercises (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AORT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.